Mercedes Alfaro Latorre

The effects of metabolic status on non‐alcoholic fatty liver disease‐related outcomes, beyond the presence of obesity

Javier Ampuero, R. Aller, Rocío Gallego‐Durán et al. · Alimentary Pharmacology & Therapeutics · 2018 · 106 citations · Full text

Medicine, Nephrology, Clinical Nutrition +16

Effectiveness of mRNA vaccine boosters against infection with the SARS-CoV-2 omicron (B.1.1.529) variant in Spain: a nationwide cohort study

Susana Monge, Ayelén Rojas‐Benedicto, Carmen Olmedo et al. · The Lancet Infectious Diseases · 2022 · 84 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

Prevalence of multiple sclerosis in the province of Teruel, Spain

P. J. Modrego Pardo, Mercedes Alfaro Latorre, A. López et al. · Journal of Neurology · 1997 · 54 citations

Life Sciences, Neurology, Epidemiology +6

Parkinsonism and Parkinson's disease associated with long-term administration of sertraline

Mercedes Alfaro Latorre, Pedro J. Modrego, F Rodilla et al. · Journal of Clinical Pharmacy and Therapeutics · 2001 · 37 citations

Medicine, Neurology, Pharmacotherapy +10

Higher levels of serum uric acid influences hepatic damage in patients with non-alcoholic fatty liver disease (NAFLD)

Conrado Fernández‐Rodríguez, R. Aller, María Luisa Gutiérrez García et al. · Revista Española de Enfermedades Digestivas · 2019 · 24 citations · Full text

Medicine, Pathobiology, Hepatology +11